BRNS - CIK 0001828185
Barinthus Biotherapeutics plc. has filed 247 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (79 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2026-05-21 | 2026-05-20 |
| New insider ownership | 3 | 2026-05-01 | 2026-05-01 |
| Quarterly report | 10-Q | 2026-04-30 | 2026-03-31 |
| Major company event | 8-K | 2026-04-30 | 2026-04-30 |
| DEFM14A | - | 2026-04-30 | - |
| Major company event | 8-K | 2026-04-22 | 2026-04-22 |
| SCHEDULE 13D | - | 2026-04-13 | - |
| Major company event | 8-K | 2026-03-31 | 2026-03-27 |
| Annual report | 10-K | 2026-03-13 | 2025-12-31 |
| Major company event | 8-K | 2026-03-13 | 2026-03-13 |
| 425 | - | 2026-02-23 | - |
| Major company event | 8-K | 2026-02-23 | 2026-02-23 |
| Major company event | 8-K | 2026-01-06 | 2025-12-30 |
| Major company event | 8-K | 2025-12-10 | 2025-12-10 |
| Quarterly report | 10-Q | 2025-11-07 | 2025-09-30 |
| Major company event | 8-K | 2025-11-07 | 2025-11-07 |
| 425 | - | 2025-09-30 | - |
| 425 | - | 2025-09-30 | - |
| Major company event | 8-K | 2025-09-30 | 2025-09-29 |
| Major company event (amended) | 8-K/A | 2025-08-08 | 2025-08-07 |
| Quarterly report | 10-Q | 2025-08-07 | 2025-06-30 |
| Major company event | 8-K | 2025-08-07 | 2025-08-07 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Insider trade | 4 | 2025-06-11 | 2025-06-10 |
| Major company event | 8-K | 2025-06-10 | 2025-06-10 |
| Quarterly report | 10-Q | 2025-05-07 | 2025-03-31 |
| Major company event | 8-K | 2025-05-07 | 2025-05-01 |
| Proxy statement | DEF 14A | 2025-04-25 | 2025-06-10 |
| Annual report to shareholders | ARS | 2025-04-25 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-25 | - |
| Annual report | 10-K | 2025-03-20 | 2024-12-31 |
| Major company event | 8-K | 2025-03-20 | 2025-03-20 |
| Employee stock plan | S-8 | 2025-03-20 | - |
| SCHEDULE 13G/A | - | 2025-02-11 | - |
| Insider trade | 4 | 2025-02-05 | 2025-02-03 |
| Insider trade | 4 | 2025-02-05 | 2025-02-03 |
| Insider trade | 4 | 2025-02-05 | 2025-02-03 |
| Insider trade | 4 | 2025-02-05 | 2025-02-03 |
| Major company event | 8-K | 2025-01-10 | 2025-01-10 |
| 3/A | - | 2024-12-31 | 2024-12-17 |
| New insider ownership | 3 | 2024-12-20 | 2024-12-17 |
| Major company event | 8-K | 2024-11-25 | 2024-11-25 |
| Major company event | 8-K | 2024-11-15 | 2024-11-15 |
| Quarterly report | 10-Q | 2024-11-06 | 2024-09-30 |
| Major company event | 8-K | 2024-11-06 | 2024-11-06 |
| Passive ownership stake (update) | SC 13G/A | 2024-11-01 | - |